A Nano-platform for Affordable and Ultra-sensitive Bio-marker Detection (2018–2021)

Lateral flow assays (LFA) are used for the rapid detection of biomarkers, however their sensitivity is relatively low. This project aims to develop a next-generation nano-platform and LFA device for ultra-sensitive detection of biomarkers. Innovative porous silica nanoparticles with uniform particle size and controllable structures will be prepared. Controlling the pore size, pore structure, internal surface functionality and density will enable higher loading of quantum dots and enhanced detection sensitivity. The outer surface modification will minimise non-specific binding and increase stability. The high value-add product will increase the competitiveness of the Parter Organisation in the rapidly growing diagnostics market.
Grant type:
ARC Linkage Projects
  • Senior Group Leader
    Australian Institute for Bioengineering and Nanotechnology
  • NHMRC Early Career Fellow
    The University of Queensland Diamantina Institute
    Faculty of Medicine
    Affiliate Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Australian Research Council